← Campbell’s overview

Campbell’s vs McCormick &: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Campbell’s Co (CPB)

Q3 2026
▼2▲1

Campbell's cuts dividend, guides weak, but plans cost cuts and price hikes

  • Dividend cut ends 56-year streak Campbell's cut its quarterly dividend by 36% to $0.25, ending a 56-year streak of increases, to fund a multiyear turnaround. This is bad news for income investors who rely on steady dividends.

    This is a major new event that directly affects investor income and signals financial stress.

  • Weak fiscal 2027 guidance and Q4 results Fiscal 2027 guidance was weak, Q4 sales fell 8% to about $2.1 billion, gross margin dropped 310 basis points, adjusted EPS fell sharply, and snacks declined with a $117 million write-down.

    These are new financial results and guidance that show deteriorating performance and drive negative sentiment.

  • Cost savings and price hikes planned Campbell's announced $500 million in cost savings by 2030 and plans 4–5% price hikes on 60% of products. These measures aim to offset inflation and improve margins over time.

    These are new strategic actions that could support future profitability and are a counterweight to the negative news.

  • Oil spike raises costs, but some brands grow An oil spike raised costs, adding pressure. Offsetting this, Campbell's still sees growth in Rao’s and Pacific soups, though inflation and lower margins may delay benefits.

    This captures both a new cost headwind and a positive offset, showing the mixed forces at play.

August 2026
▼2▲1

Campbell's cuts dividend, guides weak, but plans cost cuts and price hikes

  • Dividend cut ends 56-year streak Campbell's cut its quarterly dividend by 36% to $0.25, ending a 56-year streak of increases, to fund a multiyear turnaround. This is bad news for income investors who rely on steady dividends.

    This is a major new event that directly affects investor income and signals financial stress.

  • Weak fiscal 2027 guidance and Q4 results Fiscal 2027 guidance was weak, Q4 sales fell 8% to about $2.1 billion, gross margin dropped 310 basis points, adjusted EPS fell sharply, and snacks declined with a $117 million write-down.

    These are new financial results and guidance that show deteriorating performance and drive negative sentiment.

  • Cost savings and price hikes planned Campbell's announced $500 million in cost savings by 2030 and plans 4–5% price hikes on 60% of products. These measures aim to offset inflation and improve margins over time.

    These are new strategic actions that could support future profitability and are a counterweight to the negative news.

  • Oil spike raises costs, but some brands grow An oil spike raised costs, adding pressure. Offsetting this, Campbell's still sees growth in Rao’s and Pacific soups, though inflation and lower margins may delay benefits.

    This captures both a new cost headwind and a positive offset, showing the mixed forces at play.

Latest
▼2▲1

Campbell's cuts dividend 36% to fund a multiyear rebuild

  • Dividend slashed to fund rebuild Campbell's cut its quarterly dividend by 36% to $0.25, ending a 56-year streak of rising payments. The money will fund a multiyear turnaround. Income-focused investors lose a key reason to hold the stock, which pressures the share price.

    The dividend cut is the single biggest new event and directly hits shareholder returns.

  • Weak Q4: sales, profit and snacks all fell Quarterly sales fell 8% to $2.14 billion, adjusted profit dropped 25%, and the snack business saw organic sales fall 6% with a $117 million write-down on Kettle and Cape Cod brands. Management warned of high-single-digit declines ahead, a clear drag on the stock.

    The weak results are the fundamental reason behind the dividend cut and the selloff.

  • Price hikes and $500M cost cuts to offset inflation Campbell's is raising prices 4-5% on about 60% of its products and targeting $500 million in savings by 2030. These steps could steady profits, but with inflation at 5-6% and gross margin guided lower, the benefit may take years to show.

    This is management's main plan to fix the business, so it shapes the longer-term outlook.

  • Some brands still growing Rao's sauces and soups and Pacific soups posted solid consumption growth, and new products like Goldfish Pokemon cookies are launching. These bright spots show parts of the portfolio still attract shoppers, offering a counterweight to the weak snack business.

    It is the one genuinely positive force in the period and balances the otherwise negative picture.

▼3▲1

Campbell's Cuts Dividend, Guides Weak as Sales and Margins Fall

  • Dividend cut and weak fiscal 2027 guidance Campbell's slashed its quarterly dividend by 36% to $0.25 and guided fiscal 2027 sales and profit below estimates. The dividend cut signals management expects prolonged weakness, and weak guidance means future earnings may disappoint, pushing the stock down sharply.

    This is the core new event that directly caused the stock's double-digit drop.

  • Fourth-quarter sales, earnings, and margin declines Net sales fell 8% to $2.1 billion, gross margin dropped 310 basis points to 27.3%, and adjusted EPS fell 37% to $0.39, missing estimates. These weak results show the company is selling less and earning less per sale, which pressures the stock.

    It provides the fundamental backdrop for the sell-off and confirms deteriorating financial health.

  • New $500 million cost-saving program Campbell's announced a cost-saving program targeting $500 million in savings by fiscal 2030, starting in fiscal 2027. If successful, this could improve profits and cash flow, offering some support to the stock over time.

    It is a new initiative that could partially offset the negative news and is a real counterweight.

  • Oil spike from Iran ceasefire collapse raises costs The collapse of the Iran ceasefire caused crude oil to spike over 7%, raising freight and production costs for Campbell's. Higher costs squeeze margins, and passing them to shoppers risks losing sales, adding pressure to the stock.

    It is a new external cost shock that compounds the company's margin problems.

McCormick & Company Incorporated (MKC)

Q3 2026
▼3▲1

Unilever Deal Overhang Drives McCormick Shares Down 50%

  • Unilever deal leverage and dilution The $15.7B cash-and-stock purchase of Unilever's foods business pushes debt to 4x EBITDA and dilutes existing holders to about 35% ownership via a Reverse Morris Trust, causing shares to fall 50% from record highs.

    This is the dominant new event that explains the massive stock decline.

  • UK regulator opens probe The UK competition regulator opened an investigation into the Unilever deal, adding risk of delays or outright blockage, which weighs on investor confidence and the stock price.

    This is a new regulatory hurdle that increases uncertainty and pressures the stock.

  • Analyst downgrades on integration and share loss Analysts cut fair value and price targets, citing integration challenges, weak U.S. retail execution, and spice market share losses, which reinforced negative sentiment and contributed to the sell-off.

    These downgrades reflect new concerns that directly affect investor expectations and the stock price.

  • Strong Q3 earnings and possible Berkshire financing McCormick beat Q3 earnings expectations, reaffirmed 2026 guidance, and saw better-than-expected Flavor Solutions volume growth; possible Berkshire Hathaway financing offers a counterweight, along with a low valuation and 3.7% yield.

    These positive factors provide some support and balance the negative drivers.

September 2026
▲2▼2

McCormick's Q3 Beat Offset by Unilever Deal Risks and Analyst Caution

  • Q3 earnings beat and reaffirmed outlook McCormick reported Q3 adjusted EPS of 86 cents and revenue of $2.02 billion, both above consensus, with net sales up 17.4% and adjusted operating income of $359 million. The company reaffirmed its fiscal 2026 outlook, signaling confidence despite a tough consumer environment.

    This is the main new positive event that drove the stock up nearly 5% on the day.

  • UK regulator opens probe into Unilever Foods merger The UK Competition and Markets Authority launched an investigation into the $65 billion merger between Unilever's food business and McCormick, to assess potential harm to UK competition. The first-phase review deadline is November 11. This regulatory hurdle adds uncertainty and could delay or block the deal.

    This is a new regulatory risk that directly threatens the completion of the transformative merger.

  • Analysts cut fair value and price targets on integration and volume risks Analysts lowered McCormick's fair value to $54.85 from $60.15, with BofA trimming its target to $55 and TD Cowen downgrading to Hold with a $48 target. Concerns include weaker U.S. retail execution, share loss in spices, and risks tied to integrating the UL Foods business.

    This shows a broad reassessment of McCormick's valuation and growth prospects following the Q3 report and deal news.

  • Flavor Solutions volume growth beats expectations McCormick's Flavor Solutions segment posted 6% constant-currency sales growth in Q2, with organic growth split evenly between volume and pricing. The Americas led with 4% organic growth. Management expects this momentum to continue and drive total company volume growth for fiscal 2026.

    This is a new positive operational update that supports the growth narrative ahead of the Q3 report.

Latest
▲2▼2

McCormick's Q3 Beat Offset by Unilever Deal Risks and Analyst Caution

  • Q3 earnings beat and reaffirmed outlook McCormick reported Q3 adjusted EPS of 86 cents and revenue of $2.02 billion, both above consensus, with net sales up 17.4% and adjusted operating income of $359 million. The company reaffirmed its fiscal 2026 outlook, signaling confidence despite a tough consumer environment.

    This is the main new positive event that drove the stock up nearly 5% on the day.

  • UK regulator opens probe into Unilever Foods merger The UK Competition and Markets Authority launched an investigation into the $65 billion merger between Unilever's food business and McCormick, to assess potential harm to UK competition. The first-phase review deadline is November 11. This regulatory hurdle adds uncertainty and could delay or block the deal.

    This is a new regulatory risk that directly threatens the completion of the transformative merger.

  • Analysts cut fair value and price targets on integration and volume risks Analysts lowered McCormick's fair value to $54.85 from $60.15, with BofA trimming its target to $55 and TD Cowen downgrading to Hold with a $48 target. Concerns include weaker U.S. retail execution, share loss in spices, and risks tied to integrating the UL Foods business.

    This shows a broad reassessment of McCormick's valuation and growth prospects following the Q3 report and deal news.

  • Flavor Solutions volume growth beats expectations McCormick's Flavor Solutions segment posted 6% constant-currency sales growth in Q2, with organic growth split evenly between volume and pricing. The Americas led with 4% organic growth. Management expects this momentum to continue and drive total company volume growth for fiscal 2026.

    This is a new positive operational update that supports the growth narrative ahead of the Q3 report.

July 2026
▼2▲1

McCormick's $45B Unilever deal drives 50% share plunge and regulatory review

  • $15.7B Unilever deal crushes shares 50% on leverage fears McCormick's $15.7 billion cash-and-stock purchase of Unilever's food business pushes debt to 4x EBITDA, above its target. Investors fear the huge price paid and heavy borrowing, sending shares down 50% from record highs.

    This is the core new event explaining the massive share decline and investor concern.

  • Reverse Morris Trust structure dilutes existing shareholders The deal uses a Reverse Morris Trust, meaning McCormick issues about $29.1 billion in new shares. Unilever holders end up with roughly 65% of the combined company, leaving current McCormick owners with only 35% and heavy debt.

    Explains the mechanics of dilution that directly pressure the stock price.

  • Berkshire Hathaway interest could ease financing burden Reports suggest Berkshire's new CEO Greg Abel might invest, potentially financing the $16 billion cash need via preferred stock. McCormick's low 9x P/E and 3.7% yield make it attractive, offering a possible counterweight to the selloff.

    Provides a real positive counterweight that could support the stock if financing worries ease.

  • UK regulator opens review, adding deal uncertainty The UK competition watchdog is seeking comments on the merger until August 5. Regulatory scrutiny could delay or alter the deal, keeping a cloud over McCormick shares until the review concludes.

    New regulatory hurdle adds uncertainty that can weigh on the stock in the near term.

▼2▲1

McCormick's $45B Unilever deal drives 50% share plunge and regulatory review

  • $15.7B Unilever deal crushes shares 50% on leverage fears McCormick's $15.7 billion cash-and-stock purchase of Unilever's food business pushes debt to 4x EBITDA, above its target. Investors fear the huge price paid and heavy borrowing, sending shares down 50% from record highs.

    This is the core new event explaining the massive share decline and investor concern.

  • Reverse Morris Trust structure dilutes existing shareholders The deal uses a Reverse Morris Trust, meaning McCormick issues about $29.1 billion in new shares. Unilever holders end up with roughly 65% of the combined company, leaving current McCormick owners with only 35% and heavy debt.

    Explains the mechanics of dilution that directly pressure the stock price.

  • Berkshire Hathaway interest could ease financing burden Reports suggest Berkshire's new CEO Greg Abel might invest, potentially financing the $16 billion cash need via preferred stock. McCormick's low 9x P/E and 3.7% yield make it attractive, offering a possible counterweight to the selloff.

    Provides a real positive counterweight that could support the stock if financing worries ease.

  • UK regulator opens review, adding deal uncertainty The UK competition watchdog is seeking comments on the merger until August 5. Regulatory scrutiny could delay or alter the deal, keeping a cloud over McCormick shares until the review concludes.

    New regulatory hurdle adds uncertainty that can weigh on the stock in the near term.

Q2 2026
▲2▼1

McCormick's strong Q2 earnings beat, but Unilever deal overpay concerns linger

  • Q2 earnings beat and margin expansion McCormick reported Q2 adjusted EPS of $0.80, beating estimates, with sales up 14% and gross margin expanding 270 basis points. This shows the business is performing better than expected, which pushes the stock up.

    This is the main new positive event that directly lifted the stock.

  • Reaffirmed 2026 outlook Management reaffirmed full-year adjusted EPS guidance of $3.05 to $3.13 and sales growth of 13-17%, including the Mexico acquisition. Reassuring guidance reduces uncertainty and supports the stock price.

    Guidance reaffirmation is a key new factor that gives investors confidence.

  • Unilever deal overpay concerns persist Jim Cramer said McCormick is still reeling from its acquisition of Unilever's food business, which Wall Street views as a colossal overpay. This concern weighs on the stock, as investors worry about the high price paid.

    This is a major ongoing negative force that explains why the stock remains under pressure despite good earnings.

June 2026
▲2▼1

McCormick's strong Q2 earnings beat, but Unilever deal overpay concerns linger

  • Q2 earnings beat and margin expansion McCormick reported Q2 adjusted EPS of $0.80, beating estimates, with sales up 14% and gross margin expanding 270 basis points. This shows the business is performing better than expected, which pushes the stock up.

    This is the main new positive event that directly lifted the stock.

  • Reaffirmed 2026 outlook Management reaffirmed full-year adjusted EPS guidance of $3.05 to $3.13 and sales growth of 13-17%, including the Mexico acquisition. Reassuring guidance reduces uncertainty and supports the stock price.

    Guidance reaffirmation is a key new factor that gives investors confidence.

  • Unilever deal overpay concerns persist Jim Cramer said McCormick is still reeling from its acquisition of Unilever's food business, which Wall Street views as a colossal overpay. This concern weighs on the stock, as investors worry about the high price paid.

    This is a major ongoing negative force that explains why the stock remains under pressure despite good earnings.

▲2▼1

McCormick's strong Q2 earnings beat, but Unilever deal overpay concerns linger

  • Q2 earnings beat and margin expansion McCormick reported Q2 adjusted EPS of $0.80, beating estimates, with sales up 14% and gross margin expanding 270 basis points. This shows the business is performing better than expected, which pushes the stock up.

    This is the main new positive event that directly lifted the stock.

  • Reaffirmed 2026 outlook Management reaffirmed full-year adjusted EPS guidance of $3.05 to $3.13 and sales growth of 13-17%, including the Mexico acquisition. Reassuring guidance reduces uncertainty and supports the stock price.

    Guidance reaffirmation is a key new factor that gives investors confidence.

  • Unilever deal overpay concerns persist Jim Cramer said McCormick is still reeling from its acquisition of Unilever's food business, which Wall Street views as a colossal overpay. This concern weighs on the stock, as investors worry about the high price paid.

    This is a major ongoing negative force that explains why the stock remains under pressure despite good earnings.